Cargando…
Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis
SIMPLE SUMMARY: Molecular testing for thyroid nodules aims to predict malignancy. However, its role in guiding treatment decisions is not yet fully understood. The long-term nature of thyroid cancer and the relatively high cost of genetic tests have made it challenging to study the use of molecular...
Autores principales: | Tessler, Idit, Leshno, Moshe, Feinmesser, Gilad, Alon, Eran E., Avior, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913469/ https://www.ncbi.nlm.nih.gov/pubmed/36765745 http://dx.doi.org/10.3390/cancers15030786 |
Ejemplares similares
-
SAT523 Molecular Profile of Local vs. Regional Aggressive Thyroid Cancer: A Multicenter Study
por: Tessler, Idit, et al.
Publicado: (2023) -
SAT527 The Management Of Thyroid Cancer: Where We Started And Where We Are Heading? A Five-decades Text Mining Analysis
por: Tessler, Idit, et al.
Publicado: (2023) -
Early vs. late tracheostomy in ventilated COVID-19 patients – A retrospective study
por: Livneh, Nir, et al.
Publicado: (2021) -
Molecular mutations as a possible factor for determining extent of thyroid surgery
por: Krasner, Joshua R., et al.
Publicado: (2019) -
Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
por: Shlomai, Amir, et al.
Publicado: (2021)